| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Ballast Point Brewing & Spirits (PINT) | Goldman Sachs/ Morgan Stanley | $172.50 | n.a. | |||
| Merus B.V. (MRUS) | Citigroup/ Jefferies | $60.00 | n.a. | |||
| Noble Midstream Partners LP (NBLX) | Barclays/ Baird/ J.P. Morgan | $100.00 | n.a. | |||
| PMV Acquisition (PMVU) (u) | Cantor Fitzgerald | 10.00 | $10.00 | $10.00 | $100.00 | n.a. |
| Truck Hero (TRUK) | J.P. Morgan/ Baird/ BofA Merrill Lynch | $100.00 | n.a. | |||
| Viventia Bio (VITA) | Leerink Partners/ Cowen and Company/ Guggenheim Securities | $86.25 | n.a. | |||
| n.a. (not available) | ||||||
| u (unit offering) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| American Farmland (AFCO) | Deutsche Bank Securities/ Citigroup/ Raymond James/ RBC Capital Markets/ FBR | 6.00 | $8.00 | $8.00 | $48.00 | 1-Star |
| Mapi – Pharma Ltd. (MAPI) | JMP Securities | $57.50 | ||||
| MyoKardia (MYOK) | Credit Suisse/ Cowen and Company | 4.69 | $15.00 | $17.00 | $75.00 | 1-Star |
| Oasmia Pharmaceutical AB (OASM) | Rodman & Renshaw (a unit of H.C. Wainwright & Co.)/ Joseph Gunnar | $4.70 | $6.70 | $14.95 | N/C | |
| N/C = No Call – Stock has been listed on the NASDAQ Stockholm since 2010 and on the Frankfurt Stock Exchange since 2011. | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Oct. 19, 2015 | Manager(s) | Offered | Raised | Price | 10/23/15 | Change |
| Multi Packaging Solutions International (MPSX) | BofA Merrill Lynch/ Barclays/ Citigroup | 16.50 | $214.50 | $13.00 | $15.86 | 22.00% |
| Ferrari N.V. (RACE) | UBS Investment Bank/ BofA Merrill Lynch/ Santander | 17.18 | $893.10 | $52.00 | $56.38 | 8.42% |
| Oasmia Pharmaceutical AB (OASM) | Rodman & Renshaw (a unit of H.C. Wainwright & Co.)/ Joseph Gunnar | 2.33 | $9.47 | $4.06 | $3.90 | -3.94% |
| American Farmland (AFCO) | Deutsche Bank Securities/ Citigroup/ Raymond James/ RBC Capital Markets/ FBR | 6.00 | $48.00 | $8.00 | $7.54 | -5.75% |
| Dimension Therapeutics (DMTX) | Goldman Sachs/ Citigroup/ Wells Fargo Securities | 5.50 | $71.50 | $13.00 | $12.25 | -5.77% |
